Depression among heroin users: 12-Month outcomes from the Australian Treatment Outcome Study (ATOS)

被引:84
|
作者
Havard, Alys [1 ]
Teesson, Maree [1 ]
Darke, Shane [1 ]
Ross, Joanne [1 ]
机构
[1] Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW 2052, Australia
基金
英国医学研究理事会;
关键词
heroin dependence; depression; treatment; outcome; longitudinal;
D O I
10.1016/j.jsat.2006.03.012
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
A cohort comprising 495 heroin users were interviewed for the Australian Treatment Outcome Study and were reinterviewed at 12-month follow-up. The rate of current major depression declined significantly from 26% to 11% for the follow-up period. Those with current major depression on follow-up experienced fewer total days in treatment, but engaged in more treatment episodes. In comparison to those without depression, depressed individuals had less exposure to methadone/buprenorphine maintenance and residential rehabilitation for the follow-up period, but spent more time in detoxification. Those with current major depression on follow-up also reported heavier heroin and other drug use, more risk-taking behaviors, poorer physical health, and greater psychopathology than those without a diagnosis of current major depression. Although caution in interpreting these relationships is advised given the potential for confounding by client characteristics, the findings of this study illustrate the need to consider depression in the treatment of heroin dependence. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:355 / 362
页数:8
相关论文
共 50 条
  • [31] Heterogeneity in 12-month outcome among female and male smokers
    Swan, GE
    Javitz, HS
    Jack, LM
    Curry, SJ
    McAfee, T
    ADDICTION, 2004, 99 (02) : 237 - 250
  • [32] Patterns and costs of treatment for heroin dependence over 12 months: findings from the Australian Treatment Outcome Study
    Shanahan, Marian
    Havard, Alys
    Teesson, Maree
    Mills, Katherine
    Williamson, Anna
    Ross, Joanne
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH, 2006, 30 (04) : 305 - 311
  • [33] The Kuwait cataract outcome study: A 12-month evaluation
    Abdelmoaty, S.
    Behbehani, A. M.
    Aljazzaf, A.
    Grigis, N.
    Eslah, E.
    Marouf, T.
    Almuteri, S.
    Alzafiri, Y.
    MEDICAL PRINCIPLES AND PRACTICE, 2006, 15 (03) : 180 - 184
  • [34] Patterns and Predictors of Heroin Use, Remission, and Psychiatric Health Among People with Heroin Dependence: Key Findings from the 18-20-Year Follow-Up of the Australian Treatment Outcome Study (ATOS)
    Marel, Christina
    Wilson, Jack
    Darke, Shane
    Ross, Joanne
    Slade, Tim
    Haber, Paul S. S.
    Haasnoot, Katherine
    Visontay, Rachel
    Keaveny, Madeleine
    Tremonti, Chris
    Mills, Katherine L. L.
    Teesson, Maree
    INTERNATIONAL JOURNAL OF MENTAL HEALTH AND ADDICTION, 2023,
  • [35] Factors associated with presenteeism among employed Australian adults reporting lifetime major depression with 12-month symptoms
    Cocker, Fiona
    Martin, Angela
    Scott, Jenn
    Venn, Alison
    Otahal, Petr
    Sanderson, Kristy
    JOURNAL OF AFFECTIVE DISORDERS, 2011, 135 (1-3) : 231 - 240
  • [36] A 12-month observational study of potential organ donors in 12 Australian hospitals
    Silvester, W
    INTENSIVE CARE MEDICINE, 2002, 28 : S189 - S189
  • [37] Attempted suicide among entrants to three treatment modalities for heroin dependence in the Australian treatment outcome study (ATOS): prevalence and risk factors (vol 73, pg 1, 2004)
    Darke, S
    Ross, J
    Lynskey, M
    Teesson, M
    DRUG AND ALCOHOL DEPENDENCE, 2004, 73 (03) : 315 - 315
  • [38] Longitudinal Observation of Treatment Patterns and Outcomes for Patients with Fibromyalgia: 12-Month Findings from the REFLECTIONS Study
    Robinson, Rebecca L.
    Kroenke, Kurt
    Williams, David A.
    Mease, Philip
    Chen, Yi
    Faries, Douglas
    Peng, Xiaomei
    Hann, Danette
    Wohlreich, Madelaine
    McCarberg, Bill
    PAIN MEDICINE, 2013, 14 (09) : 1400 - 1415
  • [39] Cognitive performance and 12-month clinical outcome in first-episode of depression
    Vicent-Gil, M.
    Keymer-Gausset, A.
    Carceller-Sindreu, M.
    Serra-Blasco, M.
    De Diego-Adelino, J.
    Trujols, J.
    Perez, V.
    Alvarez, E.
    Cardoner, N.
    Portella, M. J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S795 - S796
  • [40] Psychosocial treatments for cocaine abuse - 12-month treatment outcomes
    Hoffman, JA
    Caudill, BD
    Koman, JJ
    Luckey, JW
    Flynn, PM
    Mayo, DW
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 1996, 13 (01) : 3 - 11